scPharmaceuticals Inc. (2SX.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 03:51PM CEST. Market open.
| Previous Close | 3.5200 |
| Open | 3.2600 |
| Bid | 3.1600 x 0 |
| Ask | 3.2400 x 0 |
| Day's Range | 3.0800 - 3.2600 |
| 52 Week Range | 3.0800 - 10.9000 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | 111.048M |
| Beta (5Y Monthly) | 0.09 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Thomson Reuters StreetEvents
Q1 2024 scPharmaceuticals Inc Earnings Call
Q1 2024 scPharmaceuticals Inc Earnings Call
- GuruFocus.com
scPharmaceuticals Inc (SCPH) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Despite a net loss and increased operational costs, scPharmaceuticals Inc (SCPH) reports significant progress in product development and market expansion.
- Zacks
ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Lags Revenue Estimates
scPharmaceuticals (SCPH) delivered earnings and revenue surprises of 20% and 6.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.